Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease (vol 14, 1326078, 2024)

Kocheise, Lorenz and Piseddu, Ignazio and Vonderlin, Joscha and Tjwa, Eric T. and Buescher, Gustav and Meunier, Lucy and Goeggelmann, Pia and Fianchi, Francesca and Dumortier, Jerome and Barciela, Mar Riveiro and Gevers, Tom J. G. and Beretta-Piccoli, Benedetta Terziroli and Londono, Maria-Carlota and Frankova, Sona and Roesner, Thomas and Joerg, Vincent and Schmidt, Constantin and Glaser, Fabian and Sutter, Jan P. and Fruendt, Thorben W. and Lohse, Ansgar W. and Huber, Samuel and von Felden, Johann and Sebode, Marcial and Schulze, Kornelius (2024) Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease (vol 14, 1326078, 2024). FRONTIERS IN IMMUNOLOGY, 15: 1369747. ISSN 1664-3224

Full text not available from this repository. (Request a copy)
Item Type: Article
Uncontrolled Keywords: autoimmune disease (AID); immune checkpoint inhibitors (ICI); autoimmune liver diseases (AILD); immune related adverse effects (irAEs); PD-1/PD-L1 immune checkpoint inhibitors; autoimmune hepatitis (AIH); primary sclerosing cholangites (PSC); primary biliary cholangitis (PBC)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Dr. Gernot Deinzer
Date Deposited: 22 Oct 2025 05:31
Last Modified: 22 Oct 2025 05:31
URI: https://pred.uni-regensburg.de/id/eprint/65585

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.